05-29 Monivent sees MDR process progressing according to plan FW
05-18 Monivent to continue operations following initial capital sufficiency meeting FW
05-06 Monivent raises new capital through directed share issues FW
04-30 Monivent reports marginal earnings shift as planned; CEO focuses on regulatory approvals and financing FW
04-30 Monivent AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-27 Monivent balance sheet for liquidation purposes reveals equity shortfall, extraordinary general meeting to be convened FW
04-20 Monivent moved to observation list as expected FW
04-20 Monivent moved to observation list as anticipated FW
04-20 Monivent prepares balance sheet for liquidation purposes - secures bridge loan FW
04-20 Monivent to prepare balance sheet for liquidation purposes - secures bridge loan FW
04-01 Monivent extends bridge loan through end of May FW
02-27 Monivent Narrows Operating Loss in Q4 FW
02-27 Monivent AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-18 Monivent Reports Minor Changes in Quarterly Results FW
11-18 Monivent AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-10-10 Monivent Granted First U.S. Patent FW
25-09-19 Monivent Secures SEK 8 Million Bridge Loan to Meet Immediate Capital Needs FW
25-08-29 Monivent Reports Decline in Sales and Revises Financial Targets FW
25-08-29 Monivent AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-25 Monivent Postpones Q2 Report FW
25-07-22 Monivent Granted New Patent in China (Update) FW
25-07-21 Monivent Granted New Patent in China FW
25-05-20 Monivent reduces operating loss FW
25-05-20 Monivent AB Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-23 Major reshuffle in Monivent's Board of Directors, John Haurum becomes new Chairman FW
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!